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Although CD8+ T cells are shown to mediate the protective immunity against the liver
stages of malaria parasites in mice, whether the direct presentation of malaria antigen by
major histocompatibility complex (MHC) class Imolecules expressed on the liver of infected
host is required for anti-plasmodial activity of CD8+ T cells is still unknown. Presently,
there is only one CD8+ epitope, SYVPSAEQI, derived from the circumsporozoite protein
of Plasmodium yoelii (PyCS), that mediates anti-malarial protection and is presented in the
context of a Kd molecule. Therefore, to investigate the mode of anti-plasmodial activity of
CD8+ T cells, we have previously generated C57BL/6 transgenic (Tg) mice, in which a Kd
molecule is expressed only on hepatocyte (Alb-Kd) or dendritic cell (DC; CD11c-Kd), by using
albumin promoter or CD11c promoter, respectively. We have also generated MHC-I-Kd Tg
mice, which express the Kd molecule under theMHC class I (MHC-I) promoter, as a positive
control. From splenocytes collected from CD11c-Kd Tg mice immunized with a synthetic
peptide, SYVPSAEQI, which corresponds to the CD8+ T-cell epitope of PyCS, emulsiﬁed in
incomplete Freund’s adjuvant , a PyCS-speciﬁc CD8+ T-cell line was generated. This PyCS-
speciﬁc CD8+T-cell line was then adoptively transferred into a cohort of either MHC-Kd Tg
or Alb-Kd Tg mice listed above, as well as wild-type C57BL/6 mice. Then both transferred
and non-transferred mice were challenged with live malaria parasites. We found that the
adoptive transfer of a PyCS-speciﬁc CD8+T-cell line resulted in a signiﬁcant inhibition of the
parasite burden in the liver of Alb-Kd Tg, as well as MHC-I-Kd Tg mice, but not of C57BL/6
mice. These results indicate that the Kd molecule expressed by hepatocytes is sufﬁcient
in mediating the anti-plasmodial activity of PyCS-speciﬁc CD8+ T cells in vivo.
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INTRODUCTION
Malaria is a severe disease that ranks among the most
prevalent infections in tropical areas throughout the world.
Approximately 250–300 million people become infected yearly
with relatively high rates of morbidity and mortality. The
WHO estimates that every year nearly one million children
die of malaria in Africa alone (World Health Organization
[WHO], 2008). The widespread occurrence and the increas-
ing incidence of malaria in many countries, caused by drug
resistant parasites and insecticide resistant vectors (Anopheles
mosquitoes), underscore the need for developing new meth-
ods of controlling this disease, which includes more effective
vaccines.
A number of mouse studies to date using Plasmodium yoelii
and P. berghei parasites for challenge have shown that protective
immunity against pre-erythrocytic stages is mediated in part by T
cells, particularly CD8+ T cells (Weiss et al., 1988, 1992; Rodrigues
et al., 1991, 1997; Tsuji et al., 1998; Sano et al., 2001; Schmidt
et al., 2008). Then, the essential role of major histocompatibility
complex class I (MHC-I) molecules in mediating CD8+ T-cell-
dependent anti-malarial immunity was shown by the study in
which adoptive transfer of malaria-immune splenocytes into β2
microglobulin (β2 m)-deﬁcient mice failed to confer protection
(White et al., 1996). Using transgenic (Tg) mice that express a T-
cell receptor (TCR), based on the TCR sequence of CD8+ T cells
that recognize an immunodominant T-cell epitope of the PyCS
protein, SYVPSAEQI, a recent study showed that the Tg T cells do
not require bonemarrow-derived antigen-presenting cells (APCs)
for protection upon adoptive transfer; instead, they recognize
antigen on parenchymal cells, presumably parasitized hepato-
cytes (Chakravarty et al., 2007). These studies all together strongly
suggest that MHC-I molecules expressed bymalaria-infected hep-
atocytes play a key role in mediating the anti-plasmodial activity
of CD8+ T cells in vivo. However, it is still unknown to which
extent MHC-I molecules expressed by hepatocytes mediate the
anti-plasmodial activity of CD8+ T cells in vivo.
The immunodominant T-cell epitope, SYVPSAEQI, described
above is presented by H-2Kd (Kd) molecules to CD8+ T cells and
is known to be the only epitope that can induce protective CD8+
T cells against malaria. Therefore, to provide answers concerning
the mechanisms underlying the anti-plasmodial activity of CD8+
T cells, we have taken an approach in which Tg C57BL/6 mice,
expressing H-2Kd molecules only on the surface of hepatocytes
(Alb-Kd), DCs (CD11c-Kd), or all nucleated cells (MHC-I-Kd),
have been generated (Huang et al., 2013) and used in the current
studies.
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MATERIALS AND METHODS
PARASITES AND ANIMALS
Female Anopheles stephensi mosquitoes infected with P. yoelii
17XNL strain were purchased from the New York University
insectary. P. yoelii sporozoites were isolated from the salivary
glands of infected A. stephensi mosquitoes 14 days after the
mosquitoes had received an infectious blood meal (Huang et al.,
2014). Six- to eight-week-old C57BL6 mice were purchased from
Taconic (Germantown, NY, USA). Three tissues speciﬁc H-2Kd
Tg mice models, Alb-Kd, CD11c-Kd, and major histocompatibil-
ity complex-I-Kd (MHC-I-Kd) Tg mice models, were established
in our lab, in which H-2Kd were expressed under the control of
albumin, CD11c, and MHC I promoters, respectively, in C57BL/6
mice (Huang et al., 2013, 2014). All mice were maintained under
standard conditions in The Laboratory Animal Research Center of
The Rockefeller University. Furthermore, all animal experiments
were carried out in strict accordance with the Policy on Humane
Care and Use of Laboratory Animals of the United States Public
Health Service. The protocol was approved by the Institutional
Animal Care and Use Committee (IACUC) at The Rockefeller
University (Assurance # A3081-01).
PEPTIDE, TETRAMER, AND CULTURE MEDIUM
A peptide, SYVPSAEQI, which corresponds to the CD8+ T cell
epitope of the CS protein of P. yoelii (PyCS), was synthesized by
Peptide 2.0 Inc. (Chantilly, VA, USA). An allophycocyanin (APC)-
labeledH-2Kd/SYVPSAEQI-tetramerwas generated and provided
to us by the NIH Tetramer Core Facility at Emory University. As
culture medium we used DMEM-high glucose (Life Technolo-
gies, Grand Island, NY, USA) supplemented with 10% fetal calf
serum (Thermo Scientiﬁc, Waltham, MA, USA) and 1% super-
natant derived from phorbol myristate acetate (Fisher Scientiﬁc,
Pittsburgh, PA, USA) activated EL-4 cells (Huang et al., 2013).
GENERATION OF A PyCS-SPECIFIC CD8+ T-CELL LINE
CD11c-Kd Tg mice were immunized twice with a 2-week inter-
val and intra-peritoneally with10 μg of the synthetic peptide,
SYVPSAEQI, emulsiﬁed in incomplete Freund’s adjuvant (IFA;
Sigma-Aldrich, St. Louis,MO,USA). Ten days after the last immu-
nization, splenocytes collected from immunized CD11c-Kd mice
were stimulated with radiation-attenuated (3000-rad) splenocytes
isolated fromnaiveMHC-I-Kd micepulsedwith SYVPSAEQIpep-
tide. We repeated the stimulation for a few times every 10 days,
as described Rodrigues et al. (1991), and 10 days after the last
stimulation, the frequency of PyCS-speciﬁc CD8+ T cells among
the T-cell line was determined by either Tetramer staining or an
ELISpot assay.
TETRAMER STAINING AND ELISPOT ASSAY
The speciﬁcity and frequency of a PyCS-speciﬁc CD8+ T-cell
line was determined by a ﬂow cytometric analysis after stain-
ing the T-cell line with antibodies against various CD molecules
and an APC-labeled H-2Kd/SYVPSAEQI-tetramer. All the anti-
bodies used in this study were purchased from BioLegend (San
Diego, CA, USA). Brieﬂy, cells were ﬁrst incubated with unla-
beled anti-CD16/CD32 antibody (Clone 16) for 10 min at 4◦C.
Then the cells were incubated with FITC-labeled anti CD3 anti-
body (17A2), Paciﬁc Blue-labeled anti-CD8 alpha antibody (clone
53–6.7), and APC-labeled H-2Kd/SYVPSAEQI-tetramer at room
temperature for 30 min. A ﬂow cytometric analysis was per-
formed using an LSR II ﬂow cytometer (BD Biosciences, San
Jose, CA, USA). The frequency of SYVPSAEQI-speciﬁc, IFN-γ–
secreting T cells was determined by an ELISpot assay, as previously
described Huang et al. (2013, 2014). Brieﬂy, 1000 cells of the T cell
line were co-cultured with 5 × 105 EL-4-Kd cells (Huang et al.,
2013) loaded with SYVPSAEQI in a well of an ELISpot plate.
Twenty-four hours later, the relative number of IFN-γ secret-
ing cells was determined by counting the number of spots that
corresponds to IFN-γ-secreting cells using a stereomicroscope.
The number of IFN-γ secreting cells after co-culturing with EL-
4-Kd cells without SYVPSAEQI peptide was used as negative
control.
ADOPTIVE TRANSFER AND PARASITE CHALLENGE
Tenmillion cells of PyCS-speciﬁcCD8+ T-cell linewere adoptively
transferred intravenously (i.v.) into each mouse (Rodrigues et al.,
1991). Twenty-four hours later, 1 × 104 viable P. yoelii sporozoites
were inoculated to each transferred, as well as non-transferred
mice by tail vein injection (Rodrigues et al., 1991).
ASSESSMENT OF PARASITE BURDEN IN THE LIVER
Parasite burden in the liver was determined 42 h after sporozoite
challenge by measuring the amount of parasite-speciﬁc 18S rRNA
in the liver of challenged mice, using a real-time quantitative
RT-PCR with the 7500 Fast Real-Time PCR System (Life Tech-
nologies, Grand Island, NY, USA; Huang et al., 2014). Parasite
burden was described as a ratio of the absolute copy number of
parasite-speciﬁc 18S rRNA to that of mouse GAPDH.
STATISTICAL ANALYSES
Statistical analyses were done using GraphPad Prism (version
5.03; GraphPad Software Inc., La Jolla, CA, USA). All data were
expressed as the mean ± SD of three mice. Statistical analyses of
experimental and control data were evaluated by one-wayANOVA
and Student’s t-test. A value of p<0.05 was considered statistically
signiﬁcant.
RESULTS
FREQUENCY OF PyCS-SPECIFIC CD8+ T CELLS EXPANDED IN VITRO
FROM ISOLATED SPLENOCYTES OF CD11c-Kd MICE IMMUNIZED WITH
SYVPSAEQI PEPTIDE
CD11c-Kd Tgmice were immunized twice with SYVPSAEQI pep-
tide emulsiﬁed in IFA with a 2-week interval. Then splenocytes
from peptide-immunized CD11c-Kd Tg mice were collected for
the expansion of a PyCS-speciﬁc CD8+ T-cell line in vitro, which
was achieved by stimulating the cells for a few timeswith irradiated
MHC-I-Kd Tg mouse-derived splenocytes pulsed with the SYVP-
SAEQI peptide in a 10–14-day interval, as similarly performed
previously (Rodrigues et al., 1991). After successful expansion of a
PyCS-speciﬁcCD8+ T-cell line, the speciﬁcity and frequencyof the
PyCS-speciﬁc CD8+ T-cell line were determined by either APC-
labeled H-2Kd/SYVPSAEQI-tetramer staining or IFN-γ ELISpot
assay, as shown in Figure 1. The tetramer staining results depicted
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FIGURE 1 | Frequency of a PyCS-speciﬁc CD8+ T-cell line, as determined
by either a tetramer staining or an ELISpot assay. Frequency of
PyCS-speciﬁc CD8+ T cells among theT-cell line was determined by
either a tetramer staining (A) or an IFN-γELISpot assay (B). In (A), CD3+
T cells gated with anti-CD8 antibody were stained with APC-labeled
H-2Kd/SYVPSAEQI-tetramer. The number shows the percentage of CD8+
T cells that are positive with H-2Kd/SYVPSAEQI-tetramer. In (B), 1000 cells of
theT-cell line were co-cultured with 5 × 105 EL-4-Kd cells loaded with
SYVPSAEQI in a well of an ELISpot plate, and 24 h later, the relative number
of IFN-γ-secreting cells was determined by an ELISpot assay. The number of
IFN-γ-secreting cells after co-culturing with EL-4-Kd cells without SYVPSAEQI
peptide loading was used as a negative control.
that more than two third of the cells of a PyCS-speciﬁc CD8+ T-
cell line could be identiﬁed asH-2Kd/SYVPSAEQI tetramer CD8+
T cells (Figure 1A). By assessing the ELISpot assay, more than
700 cells out of 1,000 cells of the T cell line were found to get
activated by the SYVPSAEQI peptide and secrete IFN-γ, whereas
in the absence of the SYVPSAEQI peptide, the cells did not display
any responses, indicating that there was no non-speciﬁc or auto-
reactive T cells present in the T cell line (Figure 1B). This indicates
that a majority (>65–70%) of the population in the T cell line are
speciﬁc to the SYVPSAEQI epitope.
INHIBITION OF P. yoelii HEPATIC STAGE DEVELOPMENT IN MHC-Kd
MICE AND Alb-Kd MICE AFTER ADOPTIVELY TRANSFERRING
PyCS-SPECIFIC CD8+ T CELLS
Now that we generated a PyCS-speciﬁc CD8+ T-cell line having
more than two third of the cells speciﬁc to SYVPSAEQI peptide,
FIGURE 2 | Inhibition of Plasmodium yoeli liver stage development
in MHC-Kd mice and Alb-Kd mice upon adoptive transfer of
PyCS-speciﬁc CD8+ T cells, as determined by a real-time
qRT-PCR. Each mouse of MHC-Kd Tg mice, Alb-Kd Tg mice, and wild-type
C57BL/6J mice (three mice per group) received 1 × 107cells of a
PyCS-speciﬁc CD8+ T-cell line intravenously. Twenty-four hours later, the
transferred, as well as non-transferredTg mice and wild-type C57BL/6 mice,
were challenged by 1 × 104 viable P. yoelii sporozoites. After 42 h, the
parasite burden in the liver was determined by measuring the relative copy
number of parasite-speciﬁc 18S rRNA to that of mouse GAPDH using a
real-time qRT-PCR. The mice that do not receive PyCS-speciﬁc CD8+ T-cell
transfer served as negative controls. Error bars represent means ± SEM
(n = 3). A value of p < 0.05 was considered statistically signiﬁcant, whereas
N.S. means “not signiﬁcant.”
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we sought to address one of the key questions regarding the man-
ner in which CD8+ T cells recognize and eliminate the hepatic
stage of malaria in vivo. More speciﬁcally, we aimed to deter-
mine the role of MHC-I molecules expressed on hepatocytes in
mediating CD8+ T cells’ recognition of malaria-infected hepato-
cytes and their anti-plasmodial activity in vivo. For this purpose,
we adoptively transferred 1 × 107 cells of PyCS-speciﬁc CD8+ T-
cell line to three groups (three mice each): MHC-I-Kd Tg mice (as
a positive control), Alb-Kd Tg mice and wild-type C57BL/6 mice
(as a negative control). Respective Tg mice that do not receive the
PyCS-speciﬁc CD8+ T-cell transfer were used as a negative control
for each group of transferred Tg mice. All experimental mice were
then challenged with 1 × 104 live P. yoelii sporozoites. Forty-two
hours after the challenge, the livers were collected from challenged
mice, and the liver parasite burden was determined by measuring
the parasite-speciﬁc rRNA by real-time PCR and quantiﬁed by a
ratio of the absolute copy number of parasite-speciﬁc 18S rRNA to
that of mouseGAPDH.After theP. yoelii sporozoites challenge, the
PyCS-speciﬁc CD8+ T-cell line inhibited almost 50% of the para-
site burden in the liver of MHC-I-Kd Tg mice, but not in C57BL/6
mice (Figure 2). Most importantly, a PyCS-speciﬁc CD8+ T-cell
line transferred to Alb-Kd Tg mice could inhibit (55%) the liver
stage development as potently as those transferred to MHC-I-Kd
Tg mice. These results indicate that Kd molecules expressed on
hepatocytes are sufﬁcient in mediating the anti-parasitic effect of
PyCS-speciﬁc CD8+ T cells in vivo.
DISCUSSION
The role of MHC-I molecules in mediating CD8+ T cell-
dependent immunity against the liver stages of rodent malaria
parasites has been shown by a few studies as described in the intro-
duction section (White et al., 1996; Chakravarty et al., 2007). These
studies have clearly led to a conclusion thatCD8+ Tcells are unable
to confer protection in the absence of MHC-I molecules (White
et al., 1996) and that CD8+ T cells do not require bone marrow-
derived APCs for protection (Chakravarty et al., 2007). However,
whether CD8+ T cells need to recognize MHC-I expressed on
hepatocytes in order to exert anti-plasmodial effector activity is
yet unknown. Therefore, for the purpose of addressing this key
question, we have generated B6 Tg mice that express Kd molecule
only on hepatocyte (Alb-Kd; Huang et al., 2013) in addition to
those that express Kd molecules in all nucleated cells (MHC-I-Kd;
Huang et al., 2013) and performed a set of adoptive transfer exper-
iments, in whichmalaria-speciﬁc CD8+ T cell-line was transferred
toAlb-Kd Tgmice,MHC-I-Kd Tgmice (as a positive control), and
B6 mice (as a negative control).
We ﬁrst sought to establish a PyCS-speciﬁc CD8+ T-cell
line from MHC-Kd Tg mice, which is a rather straightforward
approach. However, such T cell-line bears Kd molecule, which
should cause allogeneic reaction to wild-type C57BL/6 mice
(Kd negative) upon being adoptively transferred. Therefore, we
decided to generate a PyCS-speciﬁc CD8+ T-cell line fromCD11c-
Kd Tg mice, in which DCs express Kd molecules, and can present
SYVPSAEQI peptide to CD8+ T cells that lack Kd expression.
In the present study, we found that a PyCS-speciﬁc CD8+ T-cell
line adoptively transferred to Alb-Kd Tgmice inhibited more than
50% of the liver stage development, which is equal to the degree of
inhibition by the CD8+ T cell-line found in MHC-I-Kd Tg mice.
These results indicate that Kd molecules expressed on hepatocytes
play a major role in mediating the effector phase of anti-malaria
CD8+ T-cell response in vivo.
As we previously shown, we have also generated C57BL/6
Tg mice that express Kd only on DCs (CD11c-Kd Tg) and
macrophages (hCD68-Kd Tg; Huang et al., 2013) for the purpose
of determining the role of cells other than hepatocytes, like Kupffer
cells and DCs, in triggering PyCS-speciﬁc CD8+ T cells. How-
ever, the difﬁculty of expanding and generating a large number
of PyCS-speciﬁc CD8+ T cells from CD11c-Kd Tg or hCD68-Kd
Tg mice, thus far, has hampered us from determining the role of
DCs and Kupffer cells in mediating anti-plasmodial activity of the
CD8+ T cells. In order to generate a PyCS-speciﬁc CD8+ T-cell
line from these Kd Tg mice, we had tried different prime–boost
immunization regimens, i.e., a combination of immunizations
with a recombinant adenovirus expressing PyCS, a whole irra-
diated PySpz in addition to SYVPSAEQI peptide, unsuccessfully.
It was also documented in our previous research that CD11c-Kd
Tg or CD68-Kd Tg mice elicited much fewer number of PyCS-
speciﬁc CD8 T cells in vivo than that of MHC-I-Kd mice after
immunization with either SYVPSAEQI peptide or recombinant
adenovirus expressing PyCS (Huang et al., 2013). The maximum
number of PyCS-speciﬁc CD8+ T cells we could obtain from
a group of three immunized Kd Tg mice was 1 × 107 total
cells after stimulating them 3–4 times in vitro with radiation-
attenuated, APCs derived from MHC-I Kd Tg mice. The difﬁculty
of expanding a PyCS-speciﬁc CD8+ T-cell line in vitro may be
due to the lack of Kd expression by CD8+ T cells themselves for
presenting the peptide to each other. In any case, we are currently
attempting to breed and increase to a large number of CD11c-Kd
Tg or hCD68-Kd Tg mice, so that we will be able to expand
PyCS-speciﬁc CD8+ T cells in vivo before direct cell sorting in
the future.
ACKNOWLEDGMENT
We thank Dr. Ruth Nussenzweig and Dr. Victor Nussenzweig for
their supports and Dr. Vincent Sahi for assisting FACS analyses.
We also thank the NIH Tetramer Core Facility at Emory Uni-
versity for generating and providing an Allophycocyanin-labeled
H-2Kd/SYVPSAEQI-tetramer. Thisworkwas supportedby a grant
from NIH AI10289.
REFERENCES
Chakravarty, S., Cockburn, I. A., Kuk, S., Overstreet, M. G., Sacci, J. B., and
Zavala, F. (2007). CD8+ T lymphocytes protective against malaria liver stages are
primed in skin-draining lymph nodes. Nat. Med. 13, 1035–1041. doi: 10.1038/
nm1628
Huang, J., Li, X., Kohno, K., Hatano, M., Tokuhisa, T., Murray, P. J., et al. (2013).
Generationof tissue-speciﬁcH-2Kd transgenicmice for the studyof Kd-restricted
malaria epitope-speciﬁc CD8+T-cell responses in vivo. J. Immunol. Methods 387,
254–261. doi: 10.1016/j.jim.2012.10.019
Huang, J., Tsao, T., Zhang, M., and Tsuji, M. (2014). Circumsporozoite protein-
speciﬁcK(d)-restrictedCD8+T cellsmediate protective antimalaria immunity in
sporozoite-immunized MHC-I-K(d) transgenic mice. Mediators Inﬂamm. 2014,
728939. doi: 10.1155/2014/728939
Rodrigues, E. G., Zavala, F., Eichinger, D., Wilson, J. M., and Tsuji, M.
(1997). Single immunizing dose of recombinant adenovirus efﬁciently induces
CD8+ T cell-mediated protective immunity against malaria. J. Immunol. 158,
1268–1274.
Frontiers in Microbiology | Microbial Immunology February 2015 | Volume 6 | Article 69 | 4
Huang et al. MHC-I-expressing hepatocytes for anti-malarial CD8+ T cells
Rodrigues, M. M., Cordey, A. S., Arreaza, G., Corradin, G., Romero, P., Maryanski,
J. L., et al. (1991). CD8+ cytolytic T cell clones derived against the Plasmodium
yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3, 579–85.
doi: 10.1093/intimm/3.6.579
Sano, G., Hafalla, J. C., Morrot, A., Abe, R., Lafaille, J. J., and Zavala, F. (2001). Swift
development of protective effector functions in naive CD8(+) T cells against
malaria liver stages. J. Exp. Med. 194, 173–180. doi: 10.1084/jem.194.2.173
Schmidt, N. W., Podyminogin, R. L., Butler, N. S., Badovinac, V. P., Tucker, B. J.,
Bahjat, K. S., et al. (2008). Memory CD8 T cell responses exceeding a large but
deﬁnable threshold provide long-term immunity tomalaria. Proc. Natl. Acad. Sci.
U.S.A. 105, 14017–14022. doi: 10.1073/pnas.0805452105
Tsuji,M., Bergmann, C. C., Takita-Sonoda,Y.,Murata, K., Rodrigues, E. G., Nussen-
zweig, R. S., et al. (1998). Recombinant Sindbis viruses expressing a cytotoxic
T-lymphocyte epitope of a malaria parasite or of inﬂuenza virus elicit protection
against the corresponding pathogen in mice. J. Virol. 72, 6907–6910.
Weiss, W. R., Berzofsky, J. A., Houghten, R. A., Sedegah, M., Hollindale, M., and
Hoffman, S. L. (1992). A T cell clone directed at the circumsporozoite protein
which protects mice against both Plasmodium yoelii and Plasmodium berghei.
J. Immunol. 149, 2103–2109.
Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H., and Good, M. F. (1988).
CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immu-
nized with malaria sporozoites. Proc. Natl. Acad. Sci. U.S.A. 85, 573–576. doi:
10.1073/pnas.85.2.573
White, K. L., Snyder, H. L., and Krzych, U. (1996). MHC class I-dependent pre-
sentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for
protective immunity against Plasmodium berghei. J. Immunol. 156, 3374–3819.
World Health Organization [WHO]. (2008).World Malaria Report 2008. Fact Sheet
No 94. Geneva.
Conflict of Interest Statement:The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 30 September 2014; accepted: 20 January 2015; published online: 12 February
2015.
Citation: Huang J, Tsao T, Zhang M, Rai U, Tsuji M and Li X (2015) A sufﬁcient role
of MHC class I molecules on hepatocytes in anti-plasmodial activity of CD8+ T cells
in vivo. Front. Microbiol. 6:69. doi: 10.3389/fmicb.2015.00069
This article was submitted to Microbial Immunology, a section of the jurnal Frontiers
in Microbiology.
Copyright © 2015 Huang, Tsao, Zhang, Rai, Tsuji and Li. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org February 2015 | Volume 6 | Article 69 | 5
